DRUG · Unmapped registry intervention
Androgen Suppression
Find medicine records ·
Find other trials using this name
Clinical trial
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
NCT03570827
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
RADIATION · Unmapped registry intervention
Hypofractionated Radiation Therapy
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Quality-of-Life Assessment
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Questionnaire Administration
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedHypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Stage IIB Prostate Cancer AJCC v8unresolved
Stage III Prostate Cancer AJCC v8unresolved
Stage IIIA Prostate Cancer AJCC v8unresolved
Stage IIIB Prostate Cancer AJCC v8unresolved
Stage IIIC Prostate Cancer AJCC v8unresolved
Interventions
Sponsors & collaborators
Mayo Cliniclead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03570827 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.